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UNIT 21.3Visualization of Protein Interactions in
Living Cells Using Bimolecular Fluorescence
Complementation (BiFC) Analysis
Protein interactions control many cellular functions. The functional characteristics of
many proteins are determined by the proteins that they interact with in each cell. Interac-
tions with different partners and in response to different extracellular signals can occur in
different subcellular locations. Determination of the locations of protein complexes and
their regulation can provide insight into the functional roles of the protein interactions.
This unit describes the bimolecular fluorescence complementation (BiFC) assay for the
visualization of protein interactions in living cells (Hu et al., 2002). This approach is
based on complementation between nonfluorescent fragments of the yellow fluorescent
protein (YFP) when they are brought together by an interaction between proteins fused to
each fragment (Fig. 21.3.1). The BiFC assay allows direct visualization of the subcellular
locations of protein interactions in living cells (see Basic Protocol). This approach can
be used for the analysis of many protein interactions and does not require information
about the structures of the interaction partners.
Most proteins have a large number of alternative interaction partners in each cell. Many of
these interactions are mutually exclusive, resulting in competition for shared interaction
partners in the cell. To study the competition for interactions between alternative inter-
action partners in living cells, the authors of this unit have developed a multicolor BiFC
assay by fusing fragments of different fluorescent proteins to the interaction partners (see
Alternate Protocol 1). The multicolor BiFC assay is based on the use of fragments of
fluorescent proteins with distinct spectral characteristics. Bimolecular complexes formed
between these fragments can be visualized using different excitation and emission wave-
lengths, enabling parallel visualization of multiple interactions in the same cell. The
Figure 21.3.1 Schematic representation of the principle of the BiFC assay Two fragments (YN
and YC) of the yellow fluorescent protein (YFP) are fused to putative interaction partners (A and B).
The association of the interaction partners allows formation of a bimolecular fluorescent complex.
This black-and-white facsimile of the figure is intended only as a placeholder; for a full-color version
of the figure go to http://www.interscience.wiley.com/c p/colorfigures.htm.
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multicolor BiFC assay allows comparison of the subcellular locations of different pro-
tein interactions in the same cell, as well as analysis of the competition among mutually
exclusive interaction partners for complex formation with a common partner (Alternate
Protocol 2).
NOTE:Cells are cultured in a humidified 37◦C, 5%CO2 incubator. Cells can be incubated
in a 30◦C, 5% CO2 incubator to promote maturation of the fluorophore and thereby
increase the signal (see Commentary). Cells are maintained under conditions required
for each line (UNIT 1.1).
BASIC
PROTOCOL
VISUALIZATION OF PROTEIN INTERACTIONS IN LIVING CELLS
The BiFC assay allows direct visualization of protein interactions in living cells based on
complementation between nonfluorescent fragments ofYFP or other fluorescent proteins.
Materials
Plasmid vectors for expression of proteins of interest (also see Critical Parameter):
e.g., pFlag-CMV2 (Sigma) or pHA-CMV (Clontech)
DNA encoding amino acid residues 1 to 154 of yellow fluorescent protein (YN
fragment; also see Critical Parameters and Table 21.3.1)
DNA encoding amino acid residues 155 to 238 of yellow fluorescent protein (YC
fragment; also see Critical Parameters and
Table 21.3.1)
Linkers (see Critical Parameters)
DNA encoding proteins (interaction partners, wild-type) of interest
DNA encoding mutated, single amino acid–substitution variants of the protein of
interest that do not interact with each other (controls)
Cells that can be transfected using plasmid DNA (preferably adherent, monolayer
cell line)
Appropriate culture medium (UNIT 1.2)
FuGENE 6 (Roche Diagnostics) or other transfection reagent
Tissue culture vessels appropriate for experiment: e.g., cluster plates, slide
chambers, or glass coverslips
Inverted fluorescence microscope (UNIT 4.2) equipped with:
Sensitive CCD camera
20× to 100× objectives
Filters for visualization of YFP (excitation 500 ± 10 nm; emission 535 ± 15 nm)
Software for instrument control and data analysis
Additional reagents and equipment for expressing proteins in mammalian cells
(see APPENDIX 3A for cross-reference), mammalian cell culture (UNIT 1.1), and
immunoblotting (see UNIT 6.2)
Table 21.3.1 Selection of Fluorescent Protein Fragments for BiFC and Multicolor BiFC
Analyses
Fluorescent protein fragments Applications Filters
YN155+YC155 BiFC analysis YFP
YN173+YC173 BiFC analysis YFP
CN155+CC155 BiFC analysis CFP
YN155+CN155+CC155 Multicolor BiFC analysis CFP
YFP
Fluorescent
Protein
Technology
21.3.3
Current Protocols in Cell Biology Supplement 26
Construct plasmid vectors
1. Using the appropriate plasmid vectors, construct mammalian expression vectors by
fusing the sequences encoding amino acid residues 1 to 154 of the yellow fluorescent
protein (YN) and residues 155 to 238 (YC) to the sequences encoding protein of
interest. Whenever possible, include fusions to both the N- and C-terminal ends of
the proteins to be investigated (Fig. 21.3.2). As controls, construct plasmids encoding
mutated variants of the proteins that do not interact with each other.
For additional information about the design of fusion constructs, see Critical Parame-
ters; for cross-references to molecular biology techniques, see APPENDIX 3A. The chimeric
coding regions can be expressed in mammalian cells using vectors such as pFlag-CMV2
(Sigma) or pHA-CMV (Clontech).
As an alternative, cyan fluorescent protein (CFP) may be used as the reporter.
Prepare cells
2. Seed cells the day before transfection at a density that will allow for cell proliferation
over the course of the experiment and, at the same time, allow for the effects of cell
growth and density on the interaction under investigation.
The BiFC assay can be used for the analysis of protein interactions in many mammalian
cell lines. The authors have studied protein interactions using the BiFC assay in COS-1,
HEK293, HeLa, Hep3B, αTN4, and NIH3T3 cells (Hu et al., 2002; Grinberg et al., 2004;
Rajaram and Kerppola, 2004).
Figure 21.3.2 Multiple combinations of fusion proteins should be tested for bimolecular fluores-
cence complementation. Amino- and carboxyl-terminal fusions can be used to test eight distinct
combinations in cells that are healthy and that have a morphology similar to nontransfected cells.
This black-and-white facsimile of the figure is intended only as a placeholder; for a full-color version
of the figure go to http://www.interscience.wiley.com/c p/colorfigures.htm.
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Cluster plates are convenient for processing multiple transfections in parallel. If short-
working-distance objectives will be used to visualize the interaction, the cells should be
grown in slide chambers or on glass coverslips.
UNIT 1.1 describes basic mammalian cell culture techniques.
3. When cells reach appropriate confluence (e.g., ∼50%), transfect cells with appropri-
ate amounts (e.g., 0.25 µg) of the BiFC plasmid (from step 1) encoding the fusion
proteins. As controls, transfect cells in parallel with the plasmids encoding mutated
variants of the proteins that do not interact with each other.
FuGENE 6 from Roche Diagnostics is used according to the manufacturer’s instructions
to introduce plasmid DNA into cells, as it has low background fluorescence and requires
minimal manipulation of the cells. Users need to follow specific protocols and optimize
the conditions of transfection if other transfection reagents are used (UNITS 20.3-20.7).
4. Grow cells until fluorescence is detected (12 to 36 hr). If necessary, incubate the cells
at 30◦C with a 5% CO2 atmosphere to promote maturation of the fluorophore and to
increase the signal (however, interpret results obtained under such conditions with
care, as incubation at a lower temperature could alter protein interactions). Compare
the levels of fusion protein expression with those of the endogenous proteins by
immunoblot analysis (see UNIT 6.2).
Examine cells
5. Wash the cells with PBS to remove dead cells and debris, then add fresh medium.
6. Image the cells using an inverted fluorescent microscope with a 20× long-working-
distance objective and excitation at 500 ± 10 nm with emission detection at 535
± 15 nm. Confirm that fluorescent cells are alive and exhibit normal morphology
compared to nontransfected cells.
Higher-numerical-aperture objectives may be necessary to visualize weak signals and
higher magnification may be helpful to determine the subcellular localization.
Cells grown on coverslips can be fixed and individual proteins can be visualized by indirect
immunofluorescence analysis.
If CFP is used as the reporter, the excitation wavelength is 436 ± 5 nm and the emission
wavelength is 470 ± 15 nm.
Assess results
7. Compare results obtained with cells transfected with the wild-type interaction pro-
teins and those transfected with the control, mutant constructs with single amino acid
substitutions that prevent interactions. Compare the number of fluorescent cells ob-
served in cultures expressing fluorescent protein fragment fusions with that observed
in cultures expressing intact fluorescent proteins.
Fluorescence in a small subpopulation of cells is difficult to interpret, since itmay represent
complementation due to nonspecific interactions, or it may reflect a regulated interaction
that occurs only in response to signaling in a subset of cells.
The following conclusions may be drawn:
Specific interaction: If fluorescence is detected when wild-type proteins are expressed,
and this signal is eliminated or significantly reduced by single amino acid substitutions
that prevent the interaction, it is likely that the bimolecular fluorescence complementation
represents a specific interaction between the proteins fused to the fragments of fluorescent
proteins.
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Nonspecific interaction: If mutations that are known to eliminate the interaction do not
eliminate the fluorescence, then the bimolecular complementation is due to nonspecific
interactions between the fusion proteins. If this is the case, the BiFC assay may not be an
appropriate assay for the study of the two proteins. Alternatively, a different combination
of fusion proteins or linkers should be tested.
No fluorescence complementation detected: The lack of fluorescence complementation in
BiFC assay does not prove the absence of an interaction, even if coexpression of the
same fusion proteins with other interaction partners results in bimolecular fluorescence
complementation. Factors that may contribute to this are discussed in the Commen-
tary. Different combinations of BiFC constructs or alternative approaches should be
employed.
SUPPORT
PROTOCOL 1
QUANTIFICATION OF FLUORESCENCE COMPLEMENTATION
EFFICIENCY
Quantification of the efficiency of fluorescence complementation is useful for compar-
ison of interactions involving closely related proteins. It is particularly important for
determining whether fluorescence complementation represents a specific interaction by
comparison of wild-type and mutated proteins. The relative efficiencies of bimolecular
fluorescence complementation by structurally unrelated proteins cannot be used to deter-
mine the efficiencies of complex formation, since many factors unrelated to the efficiency
of complex formation influence the efficiency of bimolecular fluorescence complemen-
tation.
Additional Materials (also see Basic Protocol)
Plasmid encoding full-length CFP (assuming YFP fragments are used in the Basic
Protocol) or other spectrally distinguishable fluorescent protein (Clontech)
Filters for visualization of YFP (excitation 500 ± 10 nm; emission 535 ± 15 nm)
and CFP (excitation 436 ± 5 nm; emission 470 ± 15 nm)
1. Follow steps 1 to 5 of the Basic Protocol, but include 50 ng of a plasmid encoding
full-length CFP or another spectrally distinguishable fluorescent protein.
2. Image cells with a fluorescence microscope using filters optimized for separation
of CFP and YFP signals. Collect images of at least 100 cells that show detectable
fluorescence using both filter sets.
3. Quantify the fluorescence intensities using both YFP and CFP filters integrated over
the area of each cell. Subtract the background in an area of the field containing no
cells.
4. Calculate the ratio of YFP/CFP fluorescence for each cell.
This represents the complementation efficiency for the combination of proteins expressed
in individual cells.
5. Plot the data in a histogram by binning cells with similar ratios as shown in
Fig. 21.3.3.
6. Assess result.
If a mutation significantly reduces the YFP/CFP ratio compared to the wild-type pro-
tein (but the levels of expression and localization of the proteins are not altered), the
observed fluorescence is likely to represent a specific interaction between the proteins.
If the ratios are similar, the observed fluorescence signal may represent a nonspecific
fluorescence complementation, or the mutation may not affect the interaction between the
proteins.
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Figure 21.3.3 The effects of mutations that eliminate the interaction interface should be tested on
the efficiency of bimolecular fluorescence complementation (data adapted from Hu et al., 2002).
Plasmids encoding either wild-type (upper panel) or mutated (lower panel) interaction partners
were transfected into cells together with an internal reference (CFP). The fluorescence intensities
produced by bimolecular fluorescence complementation (YN-YC) and the internal reference (CFP)
were measured in individual cells. The distribution of ratios between the fluorescence intensities in
individual cells is plotted in each histogram. The dashed line indicates the maximal ratio produced
by nonspecific interactions.
ALTERNATE
PROTOCOL 1
SIMULTANEOUS VISUALIZATION OF MULTIPLE PROTEIN
INTERACTIONS IN THE SAME CELL
Comparison of the subcellular localization of different protein-protein complexes can
provide information about similarities and differences in their functions based on colo-
calization or nonoverlapping distributions of the complexes. The locations of different
complexes can be compared in different cells by using markers for various cellular struc-
tures to define the localization of each complex separately. However, it is often difficult to
find markers that precisely match the localization of a particular complex. It is therefore
preferable to compare the locations of protein complexes in the same cell. This protocol
describes a multicolor BiFC approach that enables simultaneous visualization of several
interactions in the same cell (Hu and Kerppola, 2003; Grinberg et al., 2004).
The multicolor BiFC assay is based on complementation between fragments of different
fluorescent proteins that produce bimolecular fluorescent complexes with distinct spec-
tra. These fragments are fused to alternative interaction partners such that complexes
formed with different partners can be visualized independently in the same cell using
different excitation and emission wavelengths. This approach provides a unique method
for comparison of the distributions of different protein complexes in the same cell and
for analysis of the relative efficiencies of interactions with mutually exclusive interaction
partners (Alternate Protocol 2).
Additional Materials (also see Basic Protocol)
DNA encoding amino acid residues 155 to 238 of cyan fluorescent protein (also see
Critical Parameters and Table 21.3.1)
DNA encoding proteins with altered (increased or reduced) efficiencies of complex
formation
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DNA encoding amino acid residues 1 to 154 of cyan fluorescent protein (also see
Critical Parameters and Table 21.3.1)
Interference filters for fluorescence microscope designed to minimize cross-talk
between the fluorescence signals from bimolecular fluorescent complexes
formed by fragments of different fluorescent proteins (see below)
Construct plasmid vectors
1. Using the appropriate plasmid vectors, construct mammalian expression vectors by
fusing the sequences encoding amino acid residues 155 to 238 of the cyan fluorescent
protein (CFP) to the protein whose interactions are to be investigated (this protein
is designated Z-CC155), and fuse sequences encoding amino acid residues 1 to
154 of YFP and residues 1 to 154 of CFP to two alternative interaction partners
(these proteins are designated A-YN155 and B-CN155, respectively). As controls,
construct plasmids encoding the same fusion proteins containingmutations predicted
to increase or reduce the efficiency of complex formation.
For additional information about the design of fusion constructs, see Critical Parameters;
for cross-references to molecular biology techniques, see APPENDIX 3A.
Other fluorescent proteins whose fragments produce bimolecular fluorescent complexes
with distinct spectra may be used (Hu and Kerppola, 2003; also see Critical Parameters).
Prepare cells
2. Seed cells the day before transfection at a density that will allow for cell proliferation
over the course of the experiment and, at the same time, allow for the effects of cell
growth and density on the interaction under investigation.
If short-working-distance objectives will be used to visualize the interaction, the cells
should be grown in slide chambers or on glass coverslips.
3. When cells reach appropriate confluence (e.g., ∼50%), transfect cells with an ap-
propriate amount (e.g., 0.25 µg) of the plasmid encoding A-YN155, B-CN155, and
Z-CC155. As a control, transfect each pair of expression vectors (A-YN155 and
Z-CC155 as well as B-CN155 and Z-CC155) into separate cells.
4. Grow cells until fluorescence from both complexes (i.e., A-YN155—Z-CC155 and
B-CN155—Z-CC155) is detected using filters optimized for the detection of YFP
and CFP fluorescence, respectively. If necessary, incubate the cells at 30◦C with 5%
CO2 to promote maturation of the fluorophores and to increase the signal (however,
interpret results obtained under such conditions with care, as incubation at a lower
temperature could alter protein interactions).
5. Compare the levels of expression of the proteins and adjust the amounts of plasmids
transfected if necessary.
Examine cells
6. Wash the cells with PBS to remove dead cells and debris, then add fresh medium.
7. Image the cells using an inverted fluorescent microscope with a 20× long-working-
distance objective.
To image the fluorescence emissions of A-YN155—Z-CC155 and B-CN155—Z-CC155
complexes use two filter sets with excitation at 500 ± 10 nm and emission at 535 ± 15 nm
(to detect YN—CC complexes), and excitation at 436± 5 nm and emission at 470± 15 nm
(to detect CN—CC complexes). The emission and excitation wavelengths are separated
using a dichroic mirror with transmission windows at 450 to 490 nm and 520 to 590 nm.
The fluorescence emissions of YN155—CC155 and CN155—CC155 bimolecular fluores-
cent complexes can be resolved with less than 2% cross-talk between the signals using
the filters optimized for YFP and CFP detection.
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ALTERNATE
PROTOCOL 2
ANALYSIS OF THE COMPETITION BETWEEN ALTERNATIVE
INTERACTION PARTNERS IN LIVING CELLS
The selectivity of protein interactions is determined by the relative binding affinities of
alternative interaction partners and by the local concentrations of each protein. It is diffi-
cult to predict the selectivity of protein interaction in cells based on in vitro studies, since
many factors, including covalent modifications, differences in subcellular distributions,
interactions with additional proteins, and binding affinity, can influence the selectivity of
interactions. The following protocol describes a quantitative multicolor BiFC assay that
can provide information about the relative efficiencies of complex formation by mutually
exclusive interaction partners in living cells (Hu and Kerppola, 2003; Grinberg et al.,
2004).
Principles of competition experiment
To investigate the competition between two alternative interaction partners (i.e., A and B)
for a shared partner (i.e., Z), the proteins are fused to fragments of different fluorescent
proteins that can form spectrally distinct bimolecular fluorescent complexes (i.e., A-
YN155, B-CN155, and Z-CC155). Equal concentrations of the two competing interaction
partners (i.e., A-YN155 and B-CN155) are expressed with a limiting concentration of the
shared partner (i.e., Z-CC155). The fluorescence intensities of bimolecular fluorescent
complexes formed by the alternative interaction partners (i.e., A-YN155–Z-CC155 and
B-CN155–Z-CC155) are measured in the same cells. For purposes of this protocol, the
phrase “fluorescence intensities of complexes” and variations thereof will be used to refer
to the fluorescence intensities of individual cells with specific spectral characteristics.
Additional Materials (also see Basic Protocol)
Constructs prepared in Alternate Protocol 1, step 1
Prepare cells
1. Seed cells the day before transfection at a density that will allow for cell proliferation
over the course of the experiment and, at the same time, allow for the effects of cell
growth and density on the interaction under investigation.
2. When cells reach appropriate confluence (e.g., ∼50%), transfect cells with an appro-
priate amount (e.g., 0.05 µg) of the plasmid encoding Z-CC155 to produce a limiting
concentration of the protein (established by immunoblot analysis) and appropriate
amounts (i.e., 0.25 µg) of the plasmids encoding A-YN155 and B-CN155 to pro-
duce equal amounts of these proteins that are in molar excess relative to Z-CC155.
For quantitation using absolute fluorescence intensities (see Support Protocol 2),
also transfect each pair of expression vectors (A-YN155 and Z-CC155; as well as
B-CN155 andZ-CC155) in separate cells. For quantitation using relative fluorescence
intensities (see Support Protocol 3), also transfect expression vectors encoding fu-
sions with the interaction partners fused to different combinations of fluorescent
protein fragments (i.e. A-YN155 + A-CN155 + Z-CC155; as well as B-YN155 +
A-CN155 + Z-CC155) into separate cells.
3. Grow cells until fluorescence from both complexes (i.e., A-YN155–Z-CC155 and
B-CN155–Z-CC155) is detected. If necessary, incubate the cells at 30◦C with a 5%
CO2 atmosphere to promote maturation of the fluorophore and to increase the signal
(however, interpret results obtained under such conditions with care, as incubation
at a lower temperature could alter protein interactions).
4. Compare the levels of expression of the proteins and adjust the amounts of plasmids
transfected if necessary.
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Examine cells
5. Wash the cells with PBS to remove dead cells and debris and add fresh medium.
6. Image the cells using an inverted fluorescent microscope with a 20× long working
distance objective. Identify cells that are healthy and that have a morphology similar
to nontransfected cells.
Interactions between competing partners will result in the formation of two BiFC com-
plexes, A-YN155–Z-CC155 and B-CN155–Z-CC155, with distinct spectral characteris-
tics. To image the fluorescence emissions of A-YN155–Z-CC155 and B-CN155–Z-CC155
complexes, use filters with excitation at 500 ± 10 nm and emission at 535 ± 15 nm
to detect YN–CC complexes and filters with excitation at 436 ± 5 nm and emission at
470 ± 15 nm to detect CN–CC complexes. The emission and excitation light are sepa-
rated using a dichroic mirror with transmission windows at 450 to 490 nm and 520 to
590 nm.
QUANTITATION OF MULTICOLOR BiFC ANALYSIS
The authors of this unit have developed two methods for quantification of data from
the multicolor BiFC assay that can provide information about the relative efficiencies
of complex formation by mutually exclusive interaction partners in living cells (Hu and
Kerppola, 2003; Grinberg et al., 2004). The first method, designated absolute competition
(Support Protocol 2), is based on comparison of the absolute fluorescence intensities
of bimolecular fluorescent complexes produced when a pair of interaction partners is
expressed in the presence and absenceof an alternative interactionpartner in separate cells.
The second method, designated relative competition (Support Protocol 3), is based on
comparison of the relative fluorescence intensities of bimolecular fluorescent complexes
produced when a protein is expressed together with two alternative interaction partners
in the same cells. It is best to use both methods in combination to eliminate potential
caveats inherent in each approach.
SUPPORT
PROTOCOL 2
Comparison of the Absolute Fluorescence Intensities of Bimolecular Fluorescent
Complexes Produced When a Pair of Interaction Partners Is Expressed in the
Presence and Absence of a Competitor in Separate Cells
The absolute fluorescence intensities of bimolecular fluorescent complexes are compared
when two fusion proteins are expressed alone (i.e. A-YN155+Z-CC155) and when they
are expressed in the presence of a competitor (i.e. A-YN155+B-CN155+Z-CC155)
in separate cells. This approach is designated absolute competition. This method is
well suited for analysis of large differences in the efficiencies of complex formation
between alternative interaction partners. Since it involves comparison of different cell
populations, it is subject to error due to variations between the populations. Since the
absolute fluorescence intensities vary between individual cells, this requires compari-
son of the fluorescence intensities of the populations or representative subsets of the
populations. Using this approach, it is generally possible to detect only large differ-
ences in the efficiencies of complex formation. This approach compares the fluores-
cence intensities of bimolecular fluorescent complexes formed by the same interacting
pair, in the absence and presence of competitor. This circumvents the effects of dif-
ferences in the steric arrangement of the fluorescent protein fragments between differ-
ent interaction partners that prevent comparison of the efficiencies of complex forma-
tion based on the absolute fluorescence intensities of different bimolecular fluorescent
complexes.
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Carry out Alternate Protocol 2, steps 1 to 6, then continue with the following steps.
1. Measure the fluorescence intensities of YN-CC complexes in 100 to 300 cells ex-
pressing A-YN155 + Z-CC155.
2. Measure the fluorescence intensities of YN-CC complexes in 100 to 300 cells ex-
pressing A-YN155 + B-CN155 + Z-CC155.
3. Measure the fluorescence intensities of CN-CC complexes in 100 to 300 cells ex-
pressing B-CN155 + Z-CC155.
4. Measure the fluorescence intensities of CN-CC complexes in 100 to 300 cells ex-
pressing A-YN155 + B-CN155 + Z-CC155.
5. Compare the fluorescence intensities of YN–CC complexes measured in steps 1 and
2 as well as the CN–CC complexes measured in steps 3 and 4.
6. Assess results.
Case i: If the fluorescence intensities of the two bimolecular fluorescent complexes (i.e.,
A-YN155–Z-CC155 and B-CN155–Z-CC155) expressed in the same cells are ∼50% of
the fluorescence intensities of the complexes when expressed separately, then the two
complexes form with comparable efficiencies.
Case ii: If the fluorescence intensity of one complex is similar whether it is expressed
separately or in combination, whereas the fluorescence intensity of the other complex is
reduced by >50% when expressed in combination, then the former complex forms with
higher efficiency than the latter.
Case iii: If the fluorescence intensities of both complexes expressed together are equal
or higher than those observed when they are expressed separately, then the interaction
partners do not compete for complex formation. The shared interaction partner may not
be present at limiting concentration, and the relative efficiencies of complex formation
cannot be determined based on the data.
Case iv: If the fluorescence intensities of both complexes are reduced by significantly more
than 50% when they are expressed together, or if the changes in fluorescence intensities
are not reciprocal, then the interaction partners may affect the expression or functions of
each other, and the relative efficiencies of complex formation cannot be determined based
on the data.
SUPPORT
PROTOCOL 3
Comparison of the Relative Fluorescence Intensities of Bimolecular Fluorescent
Complexes Produced when a Protein Is Expressed with Two Alternative
Interaction Partners in the Same Cells
The relative fluorescence intensities of bimolecular fluorescent complexes are compared
when a fusion protein is expressed with two alternative interaction partners fused to frag-
ments of different fluorescent proteins (i.e., A-YN155 + B-CN155 + Z-CC155). This
approach is designated relative competition. This approach is suitable for detection of rel-
atively modest differences in the efficiencies of complex formation between structurally
related alternative interaction partners. Since this approach compares complexes in the
same cells, it is less sensitive to variations between cells. However, since this approach
compares the relative fluorescence intensitites of bimolecular fluorescent complexes pro-
duced by different interaction partners, it is subject to variations in the efficiency of
association of fluorescent fragments when they are fused to different interaction partners.
Therefore, this approach can be used only when there are no large differences in the
steric constraints to association of the fluorescent protein fragments between different
complexes.
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Carry out Alternate Protocol 2, steps 1 to 6, then continue with the following steps.
1. Measure the fluorescence intensities of 100 to 300 cells expressing A-YN155 +
A-CN155 + Z-CC155 to use as a reference.
2. Measure the fluorescence intensities of 100 to 300 cells expressing A-YN155 +
B-CN155 + Z-CC155.
3. Measure the fluorescence intensities of 100 to 300 cells expressing B-YN155 +
A-CN155 + Z-CC155.
4. Plot the fluorescence intensities of YN–CC versus CN–CC complexes for each
individual cell as a scatter plot as shown in Figure 21.3.4 (middle row).
5. Compare the slopes produced by different combinations of interaction partners. The
relative slopes of these plots provide information about their relative efficiencies of
complex formation between alternative interaction partners. Alternatively, calculate
the ratio YN-CC/(YN-CC + CN-CC) and plot the data as a histogram as shown in
Figure 21.3.4 (bottom row). The distribution of ratios in the population can provide
information about the relative efficiencies of complex formation.
6. Assess results.
Case i: If the relative fluorescence intensities of both complexes display a linear rela-
tionship, and the slopes of the relationships are not significantly different, then the two
interaction partners compete with indistinguishable efficiencies for the shared partner.
Case ii: If the fluorescence intensities of both complexes display a linear relationship, and
the slopes of the relationships are significantly different, then the two interaction partners
compete with different efficiencies for the shared partner.
Case iii: If the fluorescence intensities of one or both complexes do not display a linear
relationship, or the slopes cannot be determinedwith sufficient confidence, then the relative
efficiencies of competition cannot be determined based on the data.
Comparison of Results from the Absolute and Relative Competition Approaches
The relative competition approach (Support Protocol 3) is generally more accurate for
complexeswith similar structures.However, this approach canonly be usedwhen there are
no differences in the steric constraints to association of the fluorescent protein fragments.
To confirm that the identities of the fluorescent protein fragments fused to the alternative
interaction partners do not influence the relative efficiencies of complex formation, it
is necessary to exchange the fragments between the interaction partners (i.e., compare
A-YN155 + B-CN155 + Z-CC155 with B-YN155 + A-CN155 + Z-CC155). In the
absolute competition approach, exchange of the fragments should not affect the difference
in fluorescence intensity in the presence and absence of the competitor. In the relative
competition approach, the slope of the plot of YN-CC versus CN-CC intensities should
shift in the opposite direction relative to the slope observed for the reference complexes
(A-YN155 + A-CN155 + Z-CC155). If exchange of the fluorescent protein fragments
between the interaction partners does not produce the predicted results, it is possible that
the fluorescent protein fragments influence the specificity of the interaction. In this case,
the relative efficiencies of complex formation cannot be determined using multicolor
bimolecular fluorescence complementation analysis.
Limitations of the Method
The multicolor BiFC assay for measurement of the efficiencies of protein interactions in
cells enables determination of the relative efficiencies of competition between alternative
interaction partners for a shared partner, but this does not necessarily reflect their relative
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Figure 21.3.4 Legend at right.
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binding affinities, since the complexes are not at equilibrium. The association of the
fluorescent protein fragments is relatively slow (t1/2 ≈ 60 sec) and essentially irreversible
in vitro (Hu et al., 2002). The relative efficiencies of complex formation reflect the
competition between alternative interaction partners during the time before association
of the fluorescent protein fragments. This is predicted to give a valid estimate of the
relative efficiencies of complex formation byproteinswith rapid exchange rates.However,
interaction partners with very slow rates of association may not compete efficiently for
complex formation in the assay.
Themulticolor BiFC approach is based on comparison of the relative amounts of bimolec-
ular fluorescent complexes with different spectral characteristics. Differences between
the rates of degradation of proteins in different complexes could alter the steady-state
ratio between the complexes and thereby affect the apparent efficiencies of complex for-
mation. The relative fluorescence intensities should therefore be measured at several time
pointss, and the steady-state levels of proteins should be compared by western analysis.
The rates of degradation of the complexes can be compared bymonitoring the decrease in
fluorescence in cells treated with protein-synthesis inhibitors (e.g. cycloheximide). The
rates of degradation of the fusion proteins can also bemeasured directly using pulse-chase
analysis.
Example of the Application of Quantitative Multicolor BiFC Analysis for
Determination of the Relative Efficiencies of Complex Formation
To examine the relative efficiencies of complex formation by protein Z with two alter-
native interaction partners, A and B, the authors of this unit performed an experiment
in which the proteins were fused to fluorescent protein fragments (A-YN, B-CN, and
Z-CC) and were expressed separately and in combination (Grinberg et al., 2004). The
fluorescence intensities of the alternative complexes (i.e., A-YN–Z-CC and B-CN–Z-
CC) were measured when the complexes were expressed in separate cells and when they
were expressed together in the same cell (Fig. 21.3.4A). As a reference, the fluorescent
proteins were fused to the same interaction partners (B-YN, B-CN and Z-CC), and their
fluorescence intensities were analyzed in parallel (Fig. 21.3.4B). The fluorescence in-
tensities of the complexes were plotted in scatter plots (middle panels) and histograms
Figure 21.3.4 (at Left) Multicolor fluorescence complementation analysis of the competition for
dimerization between alternative interaction partners. The relative efficiencies of complex formation
between protein Z and two alternative interaction partners, A and B, can be quantified by fusing
them to fragments of different fluorescent proteins and expressing them in different combinations.
(A) BiFC analysis of A-YN + Z-CC (green), B-CN + Z-CC (red) and A-YN + B-CN + Z-CC
(yellow). (B) BiFC analysis of B-YN + Z-CC (green), B-CN + Z-CC (red) and B-YN + B-CN +
Z-CC (yellow). (C) BiFC analysis of B-YN + Z-CC (green), A-CN + Z-CC (red) and B-YN + A-
CN + Z-CC (yellow). The diagrams at the top indicate the combinations of proteins expressed
either pairwise or in three-way competition in each experiment. The images show cells expressing
the proteins indicated below each image. The cells were imaged using filters (described in the
instrumentation section) that distinguish the fluorescence emissions of YN–CC (green) and CN–
CC (red) complexes, and the images were superimposed. The fluorescence intensities of YN–CC
complexes were plotted as a function of the fluorescence intensities of CN–CC complexes in
individual cells (middle row of graphs). The fluorescence intensities are shown in green and red
for cells that express the interaction partners pairwise, and in yellow for cells that express two
alternative interaction partners in direct competition. The best fit of a linear function to the data
from cells coexpressing three proteins is shown. The slope of this function reflects the relative
efficiencies of complex formation between the alternative interaction partners. The ratio between
the fluorescence emissions from each complex [Y/(Y + C) where Y represents YN–CC and C
represents CN–CC] was determined in individual cells in each population, and was plotted in
histograms (lower row of graphs) using the same colors as in the middle row. This black-and-white
facsimile of the figure is intended only as a placeholder; for a full-color version of the figure go to
http://www.interscience.wiley.com/c p/colorfigures.htm.
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(lower panels) when the complexes were expressed separately (red and green) and when
they were expressed together in the same cells (yellow). The ratio between the fluores-
cence intensities of the complexes reflects the relative efficiencies of complex formation
between the alternative interaction partners.
When A-YN and B-CN were coexpressed with Z-CC, the fluorescence intensities pro-
duced byA-YN–Z-CC andB-CN–Z-CC exhibited a linear relationshipwith a slope of 1.3
and a 95% confidence interval of 0.08 (Fig. 21.3.4A, middle row). In comparison, when
B-YN and B-CN were coexpressed with Z-CC, the fluorescence intensities produced by
B-YN–Z-CC and B-CN–Z-CC exhibited a linear relationship with a slope of 0.98 and a
95% confidence interval of 0.05 (Fig. 21.3.4B, middle row). Likewise, the distribution of
ratios between the fluorescence intensities [Y/(Y+C)] was shifted toward higher values
for complexes formed by A-YN and B-CN with Z-CC compared to complexes formed
by B-YN and B-CN with Z-CC (compare lower row of graphs for Fig. 21.3.4, panels A
and B). These results are consistent with the interpretation that Z favors complex for-
mation with A over complex formation with B. The absolute fluorescence intensities of
A-YN–Z-CC and B-YN–Z-CC were comparable when expressed separately, suggesting
that the efficiencies of association of the fluorescent protein fragments were comparable
under conditions where no competitors for complex formation were present.
To confirm that the fluorescent protein fragments fused to the alternative interac-
tion partners did not influence the relative efficiencies of complex formation, the au-
thors exchanged the fragments between the interaction partners (i.e., B-YN, A-CN and
Z-CC) and compared the fluorescence intensities of bimolecular fluorescent complexes
formed by these proteins (Fig. 21.3.4C). The fluorescence intensities of these complexes
exhibited a linear relationship with a slope of 0.7 and a 95% confidence interval of 0.04
(Fig. 21.3.4C, middle row). Likewise, the distribution of fluorescence intensity ratios
was shifted in the opposite directions compared to the proteins in which the fragments
were fused to the opposite interaction partners (see lower row of graphs for Fig. 21.3.4;
compare panel C with panels A and B). These data are consistent with the interpretation
that the difference between the efficiencies of bimolecular fluorescent complex formation
by A and B fusions is not due to a difference between the fluorescent protein fragments
fused to these proteins, but is caused by a difference between the efficiencies of complex
formation between A and Z versus B and Z (Grinberg et al., 2004).
Controls for Quantitative Multicolor BiFC Analysis
The use of both absolute and relative competition methods for the quantification of
relative efficiencies of complex formation is designed to correct for many of the factors
that influence the fluorescence intensities of bimolecular fluorescent complexes formed
by fragments of different fluorescent proteins. However, there are additional factors that
need to be considered and examined as follows.
1. The relative levels ofA-YN155 andB-CN155 expression affect the relative amounts of
complexes formed. The alternative interaction partners must therefore be expressed at
equal concentrations and the shared interaction partner must be expressed at a lower,
limiting concentration. All protein concentrations should preferably be within the
physiological range to observe the competition under normal cellular conditions. The
levels of protein expression can be measured by immunoblot analysis using antibodies
directed against the same epitope tag on the alternative interaction partners.
2. The efficiencies of association of different fluorescent protein fragments as well as
the fluorescence intensities of the resulting bimolecular complexes can differ. It is
therefore essential to determine the relative fluorescence intensities of the bimolec-
ular fluorescent complexes when they are brought together by the same interaction
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partners (i.e., A-YN155, A-CN155, and Z-CC155). The relative fluorescence inten-
sities of the two bimolecular fluorescent complexes (i.e., A-YN155–Z-CC155 and
A-CN155–Z-CC155) reflect both differences between the efficiencies of association
of the fluorescent protein fragments and differences between their fluorescence inten-
sities when they are brought together by the same interaction partners.
3. The relative efficiencies of bimolecular fluorescence complementation can be affected
by steric constraints imposed by the interaction partners on the association of the
fluorescent protein fragments. To investigate this possibility, the fluorescent protein
fragments can be fused to the interaction partners using several different extended
linkers. If fusion proteins containing different linkers produce identical results, then
the efficiencies of bimolecular complex formation are unlikely to be affected by steric
constraints.
4. Different fluorescent protein fragments could have differential effects on the effi-
ciencies of competition for the shared interaction partner. It is therefore essential to
exchange the fluorescent protein fragments between the interaction partners (i.e., B-
YN155, A-CN155, and Z-CC155) to determine if differences between the fluorescent
protein fragments affect the relative efficiencies of competition. This can also be veri-
fied in vitro by measuring the relative amounts of bimolecular fluorescent complexes
formed when different ratios of the fluorescent protein fragments fused to the same
interaction partners are mixed (Hu and Kerppola, 2003). If the amounts of complexes
formed are proportional to the relative concentrations of fusion proteins in the reac-
tion, then differences between the fluorescent protein fragments do not influence the
relative efficiencies of complex formation.
COMMENTARY
Background Information
The biological functions of proteins are de-
termined in large part by their interactions
with other proteins in the physiological envi-
ronment. Numerous protein interactions have
been identified using genetic screens and in
vitro binding assays. It is important to develop
experimental approaches that allow determi-
nation of the subcellular locations of these in-
teractions.
The BiFC assay has been used to visual-
ize interactions between many structurally un-
related proteins (Hu et al., 2002; Atmakuri
et al., 2003; Deppmann et al., 2003; von der
Lehr et al., 2003; Yu et al., 2003; Bracha-Drori
et al., 2004; de Virgilio et al., 2004; Farina
et al., 2004; Grinberg et al., 2004; Hynes et al.,
2004a,b; Kanno et al., 2004; Rackham and
Brown, 2004; Rajaram and Kerppola, 2004;
Remy and Michnick 2004a,b; Remy et al.,
2004; Tsuchisaka and Theologis, 2004a,b;
Tzfira et al., 2004; Walter et al., 2004; Wei
et al., 2004; Zal and Gascoigne, 2004; Zhang
et al., 2004; Zhu et al., 2004). The authors
of this unit and other investigators have deter-
mined the localization of complexes formed by
Fos, Jun, and ATF-2 (Hu et al., 2002); c-Maf
and Sox (Rajaram and Kerppola, 2004); BATF
and Jun (Deppmann et al., 2003); p65, p50, and
IkB (Hu et al., 2002); Myc, Max,Mxi1, Mad3,
and Mad4 (Grinberg et al., 2004); Skp2 and c-
Myc (von der Lehr et al., 2003); and Brd2 and
histone H4 (Kanno et al., 2004).
Protein interactions are crucial for the
control of most cellular functions. Several
methods have been developed to study pro-
tein interactions in living cells. One of the
most commonly employed methods is FRET
(UNIT 17.1). The FRET assay is based on the use
of two fluorophores either chemically linked
or genetically fused to two proteins whose in-
teraction is to be examined. Compared to the
BiFC assay, FRET analysis generally requires
higher levels of protein expression to detect en-
ergy transfer. Also, structural information or
a great deal of luck is required to place the
two fluorophores within 100 Å of each other,
which is the maximal distance over which any
significant energy transfer between fluorescent
proteins can be detected. The fraction of pro-
teins that form complexes must also be high
to produce a sufficient change in the donor
and acceptor fluorescence intensities. To ex-
clude alternative interpretations of the results,
numerous controls must be performed and the
fluorescence intensitiesmust bemeasuredwith
high quantitative accuracy. Despite these lim-
itations, FRET has been successfully used for
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the analysis ofmany protein interactions in liv-
ing cells (Sorkin et al., 2000; Li et al., 2001;
Majoul et al., 2002; Hink et al., 2003; Larson
et al., 2003; Miyawaki, 2003; Tsien, 2003).
A great advantage of FRET over BiFC anal-
ysis is the reversibility of complex formation,
which potentially allows analysis of the inter-
action under equilibrium conditions. FRET is
therefore superior for studies of the kinetics of
protein association and dissociation.
Bimolecular complementation between
fragments of a variety of proteins has been
used to investigate protein interactions in cells
(Johnsson and Varshavsky, 1994; Rossi et al.,
1997; Pelletier et al., 1998; Rossi et al., 1998;
Ghosh, 2000;Galarneau et al., 2002;Wehrman
et al., 2002; Paulmurugan andGambhir, 2003).
The basic principle is to fuse fragments of a
reporter protein to the interaction partners. Se-
lected fragments of many proteins are able to
associate with each other to produce a func-
tional complex. This complex can be detected
by the use of chromogenic or fluorogenic sub-
strates or ligands. Reporter proteins that have
been used to date include ubiquitin (Johnsson
and Varshavsky, 1994), β-glactosidase (Rossi
et al., 1997), dihydrofolate reductase (Pelletier
et al., 1998), luciferase (Paulmurugan and
Gambhir, 2003), and β-lactamase (Galarneau
et al., 2002; Wehrman et al., 2002). BiFC em-
ploys the classical principle of complemen-
tation between protein fragments (Ullmann
et al., 1967, 1968). The advantage of the
BiFC approach over other complementation
approaches is that the reconstituted fluores-
cent protein has strong intrinsic fluorescence
that allows direct visualization of the protein
complex. The complex can therefore be visual-
izedwithminimal perturbation of the cells.Us-
ing the BiFC approach, living cells can be ob-
served over long periods, and the possibility of
experimental manipulations altering the result
is minimized. Potential problemswith unequal
distributions of the chromogenic or fluoro-
genic substrates or ligands are also avoided.
Moreover, as described in Alternate Protocols
1 and 2, multiple protein interactions can be
visualized in parallel using spectrally distinct
bimolecular fluorescent complexes.
One limitation of the BiFC approach is the
time required for fluorophore maturation. This
prevents real-time detection of rapid changes
in interactions using the BiFC assay. In addi-
tion, bimolecular fluorescent complex forma-
tion is irreversible in vitro. These characteris-
tics prevent the use of the BiFC assay for stud-
ies of the dissociation and subunit exchange of
protein complexes in cells.
Characteristics of the BiFC assay
The BiFC assay has several features that
make it particularly useful for the study of pro-
tein interactions. First, it enables direct visu-
alization of protein interactions and does not
rely on their secondary effects. Second, the
interactions can be visualized in living cells,
eliminating potential artifacts associated with
cell lysis or fixation. Third, the proteins are ex-
pressed in a relevant biological context, ideally
at levels comparable to their endogenous coun-
terparts. This increases the likelihood that they
will reflect the properties of native proteins, in-
cluding any post-translational modifications.
Fourth, the BiFC assay does not require stoi-
chiometric complex formation but can detect
interactions between subpopulations of each
protein. Fifth, multicolor BiFC analysis allows
simultaneous visualization of multiple protein
complexes in the same cell and enables anal-
ysis of the competition between alternative
interaction partners for complex formation. Fi-
nally, BiFC does not require specialized equip-
ment, apart from an inverted fluorescence mi-
croscope equipped with objectives that allow
imaging of fluorescence in cells. The simple
detection of bimolecular complex formation
requires no post-acquisition image processing
for interpretation of the data.
Critical Parameters
Design of BiFC fusion constructs
The fusion proteins for BiFC analysis must
be designed with the specific proteins to be
investigated as well as the purpose of the ex-
periment in mind. Schematic diagrams of the
different permutations of fusion proteins that
can be used for BiFC analysis are shown in
Figure 21.3.2. Some general guidelines for the
design of fusion proteins for BiFC analysis are
discussed below:
Fragments of fluorescent proteins
Several combinations of fluorescent protein
fragments support bimolecular fluorescence
complementation (Hu and Kerppola, 2003).
The combinations of fluorescent protein frag-
ments recommended for BiFC analysis are
listed in Table 21.3.1. For most purposes, frag-
ments of YFP truncated at residue 155 (desig-
nated YN155, containing N-terminal residues
1 to 154, and YC155, containing of C-terminal
residues 155 to 238) are recommended, as they
exhibit a relatively high complementation ef-
ficiency when fused to many interaction part-
ners, yet produce low fluorescence when fused
to proteins that do not interact with each other.
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Fragments of YFP truncated at residue 173
(designated YN173 containing residues 1 to
172, and YC173, containing residues 172 to
238) can also be used. Other combinations
of fluorescent protein fragments can be also
used (Hu and Kerppola, 2003) as described
in the multicolor BiFC assay (see Alternate
Protocols 1 and 2).
Positions of fusions
The positions of the fusions must be de-
termined empirically to fulfill three essential
criteria:
1. The fusions must allow the fragments of
the fluorescent proteins to associate with each
other if the fusion proteins interact. Informa-
tion about the structure and location of the in-
teraction interface may be useful for this pur-
pose.However, this information is not essential
since BiFC vectors can be designed by screen-
ing multiple combinations of fusion proteins
for fluorescence complementation. A simple
strategy for the identification of fusion pro-
teins that allow bimolecular fluorescence com-
plementation is to fuse each of the fluorescent
protein fragments to theN- andC-terminal end
of each interaction partner, and to test the fu-
sion proteins for complementation in all eight
combinations that contain both fragments of
the fluorescent protein (Fig. 21.3.2).
2. The fusions must not affect the local-
ization or the stabilities of the proteins. This
should be confirmed by comparing the lo-
calization and the level of expression of the
fusion proteins with those of wild-type pro-
teins lacking the fusions using indirect im-
munofluorescence (UNIT 4.3) and immunoblot
(UNIT 6.2) analyses.
3. The fusions must not affect the func-
tions of the proteins under investigation. Ide-
ally, the protein functions should be vali-
dated using assays that evaluate all of the
known functions of the endogenous pro-
teins, and they should be performed under
the conditions used to visualize the protein
interactions.
Linkers
The linkers connect the fragments of the
fluorescent proteins to the proteins of in-
terest in the fusion proteins. The linkers
must provide flexibility for independent mo-
tion of the fluorescent protein fragments and
the interaction partners, allowing the frag-
ments to associate when the proteins in-
teract. The authors have used the RSIAT
and RPACKIPNDLKQKVMNH linker se-
quences in many fusion constructs used for
BiFC analysis (Hu et al., 2002; Hu and
Kerppola, 2003). These linkers have been used
for the visualization of interactions between
many structurally unrelated proteins. The se-
quence AAANSSIDLISVPVDSR encoded by
the multiple cloning sites of the pCMV-FLAG
vector (Sigma) has also been successfully used
as a linker in many BiFC experiments. Al-
though these linker sequences worked well in
the proteins examined, it is possible that the
length or the sequence of the linker affects
the complementation efficiency between other
proteins.
Design of constructs for multicolor BiFC
analysis
The basic principles for the design of BiFC
constructs also apply to the design of multi-
color BiFC constructs. The main difference is
the use of fluorescent protein fragments that
providemaximal spectral separation of the flu-
orescence signals from different bimolecular
complexes. There are several combinations of
fragments that can be used formulticolor BiFC
analysis (Table 21.3.1). The use of CC155 (C-
terminal fragment of CFP) paired with YN155
versus CN155 (N-terminal fragment of CFP)
provides good spectral separation and high
complementation efficiency. These combina-
tions are therefore appropriate for the simul-
taneous analysis of two protein interactions.
For the simultaneous analysis of more than
two interactions, more selective interference
filters and more complex spectral separation
algorithms are required.
Expression system
The selection of an expression system
should be based on the purpose of the experi-
ment. To determine whether a pair of proteins
can interact in cells and to determine the sub-
cellular location of the complex, a transient
overexpression system can be used. However,
overexpression of proteins in cells can result
in mislocalization of the proteins and forma-
tion of non-native complexes. To ensure that
the observed fluorescence signal reflects native
interactions, the fusion proteins should be ex-
pressed at levels comparable to the endogenous
proteins. This can be done by the use of plas-
midswithweak promoters and plasmid vectors
that do not replicate in mammalian cells. Also,
cells can be transfected using small amounts of
plasmid DNA, and they can be observed soon
after transfection.
More consistent results can be obtained by
using inducible expression vectors integrated
into the genomes of stable cell lines (e.g.,
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pIND). This allows for the control of protein
expression at relatively uniform levels in the
entire cell population.
Controls
In order to determine if any fluorescence
observed reflects a specific protein interaction,
it is essential to include negative controls in
each experiment. This is especially important
because the fluorescent protein fragments are
able to form fluorescent complexes with a low
efficiency even in the absence of a specific
interaction. This spontaneous complementa-
tion is generally reduced when the fragments
are fused to proteins that do not interact with
each other. The validity of bimolecular fluores-
cence complementation results must therefore
be confirmedusing fusions to proteins inwhich
the interaction interface has been mutated (Hu
et al., 2002; Grinberg et al., 2004). The mu-
tant proteins must be fused to the fluorescent
protein fragments in a manner identical to the
wild-type protein. The mutation must not af-
fect the stability or the subcellular location of
the fusion protein. The level of expression and
the localization of themutant protein should be
compared with the wild-type fusion protein by
immunoblot (UNIT6.2) and indirect immunoflu-
orescence analyses (UNIT 4.3). The efficien-
cies of fluorescence complementation by the
wild-type andmutant proteins should be quan-
tified and compared. If the interaction inter-
face has not been previously characterized,
it is possible to screen for mutations that al-
ter the efficiency of bimolecular fluorescence
complementation, and thereby to determine
if the complementation reflects a specific in-
teraction. The BiFC assay can therefore be
used to determine whether two proteins inter-
act in cells without prior knowledge of the lo-
cation or the structural nature of the interaction
interface.
Protein concentrations
The levels of expression of fusion proteins
used for BiFC analysis can have a profound
influence on the experimental results and on
interpretation of the data. A high level of ex-
pressionmay produce non-native protein inter-
actions, and may result in bimolecular com-
plementation independent of specific protein
interactions. It may also alter the subcellular
distributions of the fusion proteins and alter
cell functions. These may lead to the misin-
terpretation of the observed interactions. It is
therefore important to control the levels of ex-
pression of the fusion proteins and to compare
them with those of the endogenous proteins.
This can be accomplished by using regulated
expression vectors and bymaking stably trans-
fected cell lines. Differences between the lev-
els of expression of the fusion proteins and
their endogenous counterparts should also be
considered when interpreting the results from
competition studies using the multicolor BiFC
assay.
Time and temperature
The time required for the detection of fluo-
rescence varies depending on the complemen-
tation efficiency. For most productive interac-
tions, transiently transfected cells exhibit flu-
orescence at 12 to 36 hr after transfection. In
the case of some interactions, fluorescence can
be detected as early as 8 hr after transfection
(Hu et al., 2002; Grinberg et al., 2004).
Longer incubation should be avoided since
this may result in higher expression of fusion
proteins and complementation due to nonspe-
cific interaction. Since fluorophore maturation
is sensitive to high temperature, incubation at
30◦C for 30 min to several hours can increase
the signal. Keep inmind that results obtained at
30◦C should be carefully interpreted, as low-
temperature incubation may alter protein lo-
calization and/or interactions.
Interpretation of lack of fluorescence
complementation
The lack of fluorescence complementation
does not prove the absence of an interaction
because fusion of nonfluorescent fragments to
the proteins of interest can alter their struc-
tures, which could interfere with an interaction
between the proteins. Moreover, the spatial ar-
rangement of the fragments of fluorescent pro-
teins may not allow bimolecular complex for-
mation.Only in caseswhere fluorescence com-
plementation can be induced by an extracellu-
lar signal can the lack of fluorescence com-
plementation in the absence of the signal be
tentatively interpreted to reflect the absence of
an interaction or a change in complex archi-
tecture. If there is strong evidence to indicate
that the proteins interact in cells, fluorescence
complementation could be examined in differ-
ent cell types or in the presence of different
extracellular stimuli. Alternatively, additional
fusion proteins containing different linker se-
quences could be tested.
Quantification of the efficiency of
bimolecular fluorescence complementation
The efficiency of fluorescence complemen-
tation is defined as the fluorescence inten-
sity produced by bimolecular fluorescent com-
plex formation relative to the levels of fusion
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proteins present in the cell. The efficiencies of
bimolecular fluorescence complementation by
structurally unrelated proteins cannot be used
to determine their efficiencies of complex for-
mation, since many factors unrelated to the ef-
ficiency of complex formation influence the
efficiency of bimolecular fluorescence com-
plementation. However, in situations where
all of these factors are expected to be identi-
cal, differences in the efficiency of bimolecu-
lar fluorescence complementation can provide
information about the relative efficiencies of
complex formation. Thus, the effects of sin-
gle amino acid substitutions that do not alter
the level of protein expression or its localiza-
tion can be examined by quantifying the effi-
ciencies of fluorescence complementation by
the wild-type and mutated proteins (Hu et al.,
2002; Hu and Kerppola, 2003). To quantify
the efficiency of fluorescence complementa-
tion, it is necessary to include an internal con-
trol in the experiment to normalize for differ-
ences in the efficiencies of transfection and
protein expression in individual cells. For this
purpose, cells are cotransfected with plasmids
encoding the two fusion proteins together with
a plasmid encoding a full-length fluorescent
protein with distinct spectral characteristics
(e.g., CFP). The fluorescence intensities de-
rived fromboth bimolecular fluorescence com-
plementation (i.e., YFP) and the internal con-
trol (i.e., CFP) aremeasured in individual cells.
The ratio of YFP to CFP emission is calcu-
lated after subtraction of background signal
(Fig. 21.3.3). The ratio of YFP to CFP fluores-
cence is ameasure of the efficiency of bimolec-
ular fluorescence complementation. For struc-
turally related proteins under carefully con-
trolled conditions, the efficiency of comple-
mentation can provide information about the
efficiency of the protein interaction.
Anticipated Results
If the fusion proteins under investigation
support fluorescence complementation within
12 to 36 hr after transfection, it is likely that
the complementation reflects a specific inter-
action. This possibility must be verified by the
analysis of mutated proteins. For proteins that
display complementation after longer times,
it is increasingly probable that the comple-
mentation results from a nonspecific associa-
tion. If eight different combinations of amino-
and carboxy-terminal fusions are tested and no
complementation is observed, it is unlikely that
additional combinations will produce fluores-
cence complementation, although this does not
exclude the possibility that the proteins may
interact.
Time Considerations
The construction of plasmid vectors for
BiFC and multicolor BiFC analysis can be
accomplished in 1 to 2 weeks. For transfec-
tion, preparation of the cells takes 1 day and
transfection takes 1 hr using FuGENE 6. Next,
1 to 2 days incubation at 37◦C is required.
To promote chromophore maturation, incuba-
tion at 30◦C for 30 min to several hours or
overnight may be necessary. Imaging of the
cells may take a few hours depending on how
the data will be analyzed. Quantitative analy-
sis requires about half a day to 1 day for each
experiment. If everything goes smoothly, 3 to
4 weeks should be enough to obtain prelimi-
nary results. However, it takes much longer to
validate the results by performing all the neces-
sary controls. Confirmation of the interaction
using cells stably transfected with inducible
expression vectors also takes longer, since it
requires the establishment of stable cell lines
expressing the fusion proteins.
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